Cryo Cell International Inc
CCEL- Exchange
- NYSE
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0000862692
No open-market purchases or sales by Cryo Cell International Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $1.77M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Cryo Cell International Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- 0 vs. Q2 2023
- Shares held
- 842.0K
- +13.4K (+1.6%) vs. Q2 2023
- Total value
- $4.43M
- −$609.2K (−12.1%) vs. Q2 2023
- New holders
- 1
- 4 more added
- Sold out
- 1
- 2 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $1.77M |
| Q1 2026 | 11 | $1.89M |
| Q4 2025 | 17 | $3.38M |
| Q3 2025 | 20 | $4.59M |
| Q2 2025 | 20 | $5.17M |
| Q1 2025 | 21 | $6.57M |
| Q4 2024 | 20 | $7.64M |
| Q3 2024 | 14 | $5.74M |
| Q2 2024 | 14 | $6.82M |
| Q1 2024 | 14 | $6.52M |
| Q4 2023 | 15 | $4.97M |
| Q3 2023 | 12 | $4.43M |
| Q2 2023 | 12 | $5.04M |
| Q1 2023 | 12 | $2.50M |
| Q4 2022 | 14 | $4.33M |
| Q3 2022 | 14 | $4.25M |
| Q2 2022 | 13 | $4.45M |
| Q1 2022 | 12 | $5.70M |
| Q4 2021 | 14 | $10.1M |
| Q3 2021 | 10 | $7.88M |
| Q2 2021 | 3 | $1.30M |
| Q1 2021 | 2 | $895.0K |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Cryo Cell International Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 1 | $0 | 0.00% | −51−98.1% | Reduced |
| Wells Fargo & Company | 27 | $142 | 0.00% | +2+8.0% | Added |
| JPMorgan Chase & Co | 107 | $563 | 0.00% | +107 | New |
| Morgan Stanley | 400 | $2.10K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,500 | $23.7K | 0.00% | +2,000+80.0% | Added |
| BlackRock Inc. | 13,408 | $70.5K | 0.00% | −553−4.0% | Reduced |
| Cerity Partners LLC | 19,563 | $102.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 20,952 | $110.3K | 0.00% | +1,871+9.8% | Added |
| Vanguard Group Inc | 83,883 | $441.2K | 0.00% | +10,095+13.7% | Added |
| Massmutual Trust Co FSB | 124,135 | $653.0K | 0.02% | 00.0% | Unchanged |
| SFI Advisors, LLC | 165,300 | $869.5K | 0.85% | 00.0% | Unchanged |
| Hamilton Lane Advisors LLC | 409,734 | $2.16M | 1.21% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −85−100.0% | Sold out |